Literature DB >> 21431920

[Seborrheic dermatitis].

R Aschoff1, W Kempter, M Meurer.   

Abstract

Seborrheic dermatitis is a frequent skin disorder in infancy and adulthood. It also often occurs in patients with HIV or neurologic disorders like Parkinson disease or mood disorders. It is characterized by greasy, yellow flakes or scales in areas of high sebaceous gland activity like the scalp, face, chest and upper back. Additionally, erythema and itching can be present. The etiology and pathogenesis of seborrheic dermatitis is unknown; however, the focus lies on the involvement of Malassezia yeasts or fatty acid metabolites of Malassezia, on hormones and immunologic factors. The diagnosis is usually a clinical one, based on history and the appearance and site of lesions. The therapy consists mainly of antifungal agents, corticosteroids, immunomodulators, and keratolytics. Because of the chronicity of the illness with frequent relapses, a treatment strategy in which effectiveness and potential side effects are weighed should be used.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21431920     DOI: 10.1007/s00105-010-2119-0

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  19 in total

1.  The safety of ketoconazole shampoo for infantile seborrheic dermatitis.

Authors:  R T Brodell; S Patel; J S Venglarcik; D Moses; D Gemmel
Journal:  Pediatr Dermatol       Date:  1998 Sep-Oct       Impact factor: 1.588

2.  Epidemiologic Study of Malassezia Yeasts in Seborrheic Dermatitis Patients by the Analysis of 26S rDNA PCR-RFLP.

Authors:  Byung Ho Oh; Yang Won Lee; Yong Beom Choe; Kyu Joong Ahn
Journal:  Ann Dermatol       Date:  2010-05-17       Impact factor: 1.444

3.  Evaluation of the efficacy and tolerability of oral terbinafine (Daskil) in patients with seborrhoeic dermatitis. A multicentre, randomized, investigator-blinded, placebo-controlled trial.

Authors:  E Scaparro; G Quadri; G Virno; C Orifici; M Milani
Journal:  Br J Dermatol       Date:  2001-04       Impact factor: 9.302

4.  The role of sebaceous gland activity and scalp microfloral metabolism in the etiology of seborrheic dermatitis and dandruff.

Authors:  Byung In Ro; Thomas L Dawson
Journal:  J Investig Dermatol Symp Proc       Date:  2005-12

Review 5.  [The sebaceous gland].

Authors:  C C Zouboulis
Journal:  Hautarzt       Date:  2010-06       Impact factor: 0.751

6.  Prevalence of scalp scaling in prepubertal children.

Authors:  Judith V Williams; Lawrence F Eichenfield; Bonnie L Burke; Myra Barnes-Eley; Sheila F Friedlander
Journal:  Pediatrics       Date:  2005-01       Impact factor: 7.124

7.  Pimecrolimus 1% cream, methylprednisolone aceponate 0.1% cream and metronidazole 0.75% gel in the treatment of seborrhoeic dermatitis: a randomized clinical study.

Authors:  Demet Cicek; Basak Kandi; Selma Bakar; Dilara Turgut
Journal:  J Dermatolog Treat       Date:  2009       Impact factor: 3.359

Review 8.  Facial seborrheic dermatitis: a report on current status and therapeutic horizons.

Authors:  Joseph Bikowski
Journal:  J Drugs Dermatol       Date:  2009-02       Impact factor: 2.114

Review 9.  Surface lipids as multifunctional mediators of skin responses to environmental stimuli.

Authors:  Chiara De Luca; Giuseppe Valacchi
Journal:  Mediators Inflamm       Date:  2010-10-20       Impact factor: 4.711

10.  Clinical efficacies of shampoos containing ciclopirox olamine (1.5%) and ketoconazole (2.0%) in the treatment of seborrhoeic dermatitis.

Authors:  Ravi C Ratnavel; Ruth A Squire; Graham C Boorman
Journal:  J Dermatolog Treat       Date:  2007       Impact factor: 3.359

View more
  1 in total

1.  Maintenance Therapy of Facial Seborrheic Dermatitis with 0.1% Tacrolimus Ointment.

Authors:  Hye One Kim; Yoon Seok Yang; Hyun Chang Ko; Gyung Moon Kim; Sang Hyun Cho; Young Joon Seo; Sang Wook Son; Jong Rok Lee; Joong Sun Lee; Sung Eun Chang; Jae We Che; Chun Wook Park
Journal:  Ann Dermatol       Date:  2015-10-02       Impact factor: 1.444

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.